---
title: "Quantinuum (QNT) Stock Could Be Overvalued As Quantum AI Partnership Expands"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/306387857.md"
description: "Quantinuum (QNT) stock is down 54.1% YTD, raising questions about its valuation despite expanded quantum AI partnerships with RIKEN and SoftBank. Trading at a P/S ratio of 43.1x, significantly higher than the IT industry average of 1.7x, the stock appears overvalued on sales metrics. While analysts suggest it may be undervalued based on future growth potential, the current premium reflects high optimism for commercial scaling amidst ongoing losses."
datetime: "2026-11-22T08:21:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/306387857.md)
  - [en](https://longbridge.com/en/news/306387857.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/306387857.md)
generator: "portal-rs"
---

# Quantinuum (QNT) Stock Could Be Overvalued As Quantum AI Partnership Expands

Quantinuum has seen its share price fall sharply this year, which puts fresh attention on whether the current valuation lines up with the revenue the business is actually generating. With the stock under pressure despite headline partnerships, the question is how much investors are paying today for each dollar of sales.

-   The share price is down 54.1% year to date, so the market is already re-pricing what Quantinuum’s sales profile may be worth.
-   The expanded collaboration with RIKEN and SoftBank around quantum AI infrastructure may support expectations for future sales growth, but it also raises questions about the level of spending needed to reach that potential.
-   The analysts covering Quantinuum have run their own numbers. See what analysts think Quantinuum's shares could be worth.

The issue now is whether Quantinuum's current share price is justified by its sales when compared with the industry average.

If you want a broader yardstick for Quantinuum’s quantum and AI ambitions, try comparing it with 22 quantum computing stocks.

### Is Quantinuum Getting Expensive on Sales?

P/S is the cleaner lens for Quantinuum because the business is still loss making on free cash flow, so revenue is the clearest anchor for what investors are paying for today.

On this metric, the stock trades on a P/S of 43.1x, against an IT industry average of 1.7x and a peer group around 1.1x. That is a very large premium to both the wider sector and closer comparables. This means each dollar of Quantinuum’s sales is being valued far more highly than the typical technology company. Despite the expanded RIKEN and SoftBank partnership around quantum AI supercomputing, the current P/S level already reflects a lot of optimism about how the commercial model will scale.

Such a wide gap to the industry suggests Quantinuum screens as overvalued on this single metric, and the DCF framework is heavily penalising the company’s current losses and risk profile rather than pointing to a precise fair P/S target. For anyone considering the shares, the key question is whether the quality and durability of future revenue can justify paying this much above the sector on a sales basis. Explore the numbers behind Quantinuum's P/S valuation.

### The Quantinuum Narrative: What Would Justify Today's Price?

Simply Wall St Narratives pick up where the P/S puzzle leaves off for Quantinuum by spelling out what kind of future growth, margins and earnings profile would need to hold for the stock to look meaningfully richer or cheaper than today’s quote. Each narrative is set up as a clear, testable view on Quantinuum's business that you can track over time, and they sit on the company’s Community page.

**One of the top narratives on Quantinuum: 67% undervalued**

This Narrative is the analyst consensus Narrative on Simply Wall St, which compiles analysts' consensus price target and revenue and earnings forecasts, not one person's view.

> *"Quantinuum is integrating quantum systems with AI and high performance computing through partners such as Oracle and HPE, which can deepen usage of Helios and future systems..."*

Discover why this Narrative puts Quantinuum at 67% undervalued.

### One more Quantinuum check belongs beside the headline P/S story

Price is only part of the picture for Quantinuum, since Simply Wall St’s broader review has highlighted specific risk checks that investors may want to weigh before getting too comfortable. Take a closer look at 2 warning signs before settling on a valuation.

### Related Stocks

- [QNT.US](https://longbridge.com/en/quote/QNT.US.md)
- [QNTU.US](https://longbridge.com/en/quote/QNTU.US.md)
- [9984.JP](https://longbridge.com/en/quote/9984.JP.md)

## Related News & Research

- [Quantum computing’s first real-world payoff may come in energy, not drug discovery](https://longbridge.com/en/news/306384893.md)
- [Quantinuum (QNT) Could Be 51% Undervalued As Losses Cloud Its Latest Update](https://longbridge.com/en/news/305240880.md)
- [Quantinuum et RIKEN renforcent leur partenariat afin d'accélérer la commercialisation du supercalcul hybride quantique-IA au Japon](https://longbridge.com/en/news/305161761.md)
- [Quantinuum Stock Surges After Beating Q3 Expectations](https://longbridge.com/en/news/304677439.md)
- [Quantinuum Participates in Cantor Convergence Crypto, FinTech, AI & Energy Infrastructure Conference](https://longbridge.com/en/news/304907207.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**